A small change at the end of the molecule

The INCI name Retinal identifies vitamin A’s aldehyde form. An aldehyde has a carbon double-bonded to oxygen and bonded to hydrogen at the end of a molecular segment. Retinol instead has an alcohol group; retinoic acid has a carboxylic acid group. These are related molecules, not three spellings of one ingredient. [1]

Changing a small part of a molecule can change its reactions and biological handling. The suffixes are therefore useful clues: “-ol” often signals an alcohol, while “-al” can signal an aldehyde. This is why reading the precise ingredient name tells us more than the general phrase “vitamin A.”

Skin handles vitamin A through a network

A 1998 experiment followed labelled retinaldehyde and retinol in cultured human keratinocytes, the main cells of the epidermis. More differentiated cells accumulated more retinoic acids, alongside changes in a cellular retinoic-acid-binding protein. The study connects the cell’s state of maturation with its handling of vitamin A, rather than suggesting that every cell makes the same conversion. [2]

Differentiation is the process by which a cell develops specialised features. In the epidermis, cells change as they move towards the surface. A laboratory can separate these stages to ask how metabolism differs. That is valuable mechanistic information, while application to intact skin adds a delivery barrier and a complete product around the ingredient.

The documented pathway also includes conversion of retinal to retinol and retinyl esters. Retinyl esters are vitamin A attached to fatty-acid-derived groups and can serve as storage forms. This branching behaviour is a better picture than a conveyor belt that sends every applied molecule straight to retinoic acid. [3]

How the ingredient reaches a cosmetic

One documented manufacturing route uses biofermentation with the salt-loving microorganism Halobacterium salinarum. The producer supplies the resulting retinal in different carriers, including glycerin-based and oil-based forms. Fermentation describes a production route; the carrier describes how the ingredient is presented for incorporation into a product. [3]

Another manufacturer describes a retinal–cyclodextrin system using a temporary hemiacetal attachment to improve stability. A cyclodextrin is a ring-shaped carbohydrate. This example shows that delivery technology can involve chemical association as well as simply enclosing a molecule in a capsule. [4]

For the person using skincare, the important point is what a delivery system is trying to achieve: keep the ingredient available and distribute it through a suitable base. A carrier can also change how a preparation feels. The word “encapsulated” alone does not establish that two products use the same technology or have the same performance.

The long trial and the comparison that matters

Creidi and colleagues enrolled 135 adults aged 35–70 in a 44-week trial of nightly 0.05% retinaldehyde cream, 0.05% retinoic acid cream or retinaldehyde’s vehicle. Usable skin replicas from 125 participants allowed measurement of crow’s-feet wrinkles and roughness. Retinal improved from baseline, particularly at week 18; retinoic acid caused more irritation. [5]

A before-and-after comparison asks whether a group changed. A between-group comparison asks whether the tested treatment produced a different change from its comparator. Both can appear in one paper, and they answer different questions. Skin replicas add an objective surface measurement, but the analysis still needs the appropriate comparison.

What a two-strength trial adds

Kwon and colleagues randomised 40 Korean women to 0.05% or 0.1% retinaldehyde creams twice daily for three months. Both groups improved texture, hydration and water-loss measurements, without a significant difference between strengths. Only the 0.1% group significantly improved its melanin index from baseline. [6]

This is useful evidence about tolerability and measured changes in those preparations. It also shows why a higher number on a label should not be treated as a promise of a proportionally larger result.

Newer research follows combinations

A 2026 split-face trial tested 0.1% retinal with 10% azelaic acid in an anhydrous concentrate mixed with moisturiser before application. Among 23 completers aged 16–49, texture, redness and pore measurements improved versus vehicle after eight weeks. This mixed adolescent–adult study tested a combination, not retinal alone; all authors listed Skinome Research affiliations. [7]

A split-face design lets the same person receive two treatments on different sides, reducing some differences between participants. It is particularly helpful for a formulation question. Here, the meaningful finding belongs to the tested combination and application method.

Tolerance is part of the benefit

Retinoid products can irritate skin. Dermatology guidance supports gradual introduction, moisturising and daytime sun protection; irritation can also provoke dark marks in susceptible skin. Retinoids should be avoided during pregnancy. A dermatologist can help assess suitability when skin is already inflamed or a medical condition needs treatment. [8]

Retinal is best understood as a distinct vitamin A molecule with both biological plausibility and topical human research. Its useful story combines chemical identity, a carrier that keeps it available, and the experience of skin over time—not conversion steps alone.

Sources to follow

1. COSMILE Europe: Retinal. Ingredient identity.
2. Chatellard-Gruaz and colleagues, 1998. Primary keratinocyte metabolism experiment.
3. Retinal manufacture and carriers. Primary manufacturer account of fermentation and retinal pathways.
4. Retinal–cyclodextrin delivery system. Primary manufacturer description, not independent clinical evidence.
5. Creidi and colleagues, 1998. Full primary controlled photoaging trial; DOI 10.1016/S0190-9622(98)70270-1.
6. Kwon and colleagues, 2018. Primary randomised two-strength cream trial.
7. Gaudicheau and colleagues, 2026. Primary retinal–azelaic acid combination trial.
8. American Academy of Dermatology: retinoids. Professional tolerance and pregnancy guidance.